Related Experiment Video
Updated: Sep 5, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Living Donor Kidney Transplantation in a Covid-19-Recovered Donor- Recipient Pair: A Case Report
Nidhi Agrawal1, Rabi Ranjan Sow Mondal1, Deepak S Ray1
1Department of Nephrology, Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, West Bengal, India.
Insights
Living donor kidney transplantation is feasible in patients recovered from COVID-19. Careful pre-transplant screening for SARS-CoV-2 infection is crucial for successful outcomes in organ transplant candidates.
Area of Science:
- Nephrology
- Transplantation
- Infectious Diseases
Background:
- Solid organ transplantation decisions are complex during the COVID-19 pandemic.
- Patients with chronic diseases require continued access to life-saving treatments.
- The pandemic's persistence necessitates adapting transplant protocols.
Observation:
- A case of living donor kidney transplantation was performed in a donor-recipient pair who had recovered from COVID-19.
- Standard immunosuppression protocols were maintained post-transplantation.
- Both donor and recipient underwent thorough pre-transplant evaluation.
Findings:
- The transplant procedure resulted in a good early post-transplant outcome.
- No active SARS-CoV-2 infection was detected pre-transplant.
- The patient's recovery from COVID-19 did not preclude successful transplantation.
Implications:
- Solid organ transplantation can proceed safely in selected COVID-19-recovered individuals.
- Rigorous screening for SARS-CoV-2 is essential to prevent transmission and ensure patient safety.
- This approach allows for continued management of end-stage renal disease during the pandemic.
Abstract:
Deciding on proceeding with solid organ transplant in the coronavirus disease 2019 (COVID-19) era is difficult both for the transplant unit and the transplant candidate. However, with no signs of the pandemic coming to an end and given the plight of patients with chronic diseases, it becomes necessary to take the challenging path. We report a case of living donor kidney transplantation in a COVID-19-recovered donor-recipient pair with a good early posttransplant outcome. Immunosuppression was used in the usual dose as per our unit's protocol. Thorough pretransplant evaluation to rule out active SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection in both the donor and the recipient seems to be the key to avoid COVID-19 in the recipient and the transplant unit.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

